Article By:
Terry Chrisomalis
Friday, June 26, 2015 7:34 AM EDT
Shares of Celladon are down 40% pre-market after announcing suspension of Mydicar program and other pre-clinical programs.
In this article: CLDN
Monday Morning Pre-Market Insights: CLDX, CLDN, CTIC, TGTX
Wow! $CLDN gives me goose bumps! I'm very bullish.